A carregar...
Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy
Drug delivery to malignant tumors is limited by several factors, including off-target toxicities and suboptimal benefits to cancer patient. Major research efforts have been directed toward developing novel technologies involving nanoparticles (NPs) to overcome these challenges. Major obstacles, howe...
Na minha lista:
| Publicado no: | Front Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6196266/ https://ncbi.nlm.nih.gov/pubmed/30374303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01154 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|